The Lightengale® story and IVT system is gaining attention in cities and hospitals around the world. Browse press and news coverage of our illuminated system. For press inquiries, please contact our team via our online contact form.
Lightengale®, an innovator in intravenous tubing (IVT) systems, announced that they received
Safer Technologies Program (STeP) designation from the Food and Drug Administration (FDA)
for their illuminated IVT system.
Lightengale®, an innovator in intravenous tubing (IVT) systems, announced that it won a grant through the FDA Pediatric Device Consortium.
Lightengale®, an innovator in intravenous tubing (IVT) systems, announced that it won a second grant through the Small Business Technology Transfer program (STTR).
Lightengale®, an innovator in intravenous tubing (IVT) systems, announced that it received a $298,000 grant from the National Institutes of Health (NIH) as part of the Small Business Technology Transfer program (STTR).
Hans Utz of Lightengale® joins Dana Barrett for a "Tech Tuesday" discussion about solving problems with line tracing in the ICU.
In fall 2014, entrepreneur Hans Utz spent long days in the ICU, watching over his newborn who suffered from a rare congenital heart defect.
After losing a son, Lightengale® founder Hans Utz was motivated to bring a change to the intensive care units he experienced during his child’s care.
Hans Utz of Lightengale joins Dana Barrett for a "Tech Tuesday" discussion about solving problems with line tracing in the ICU.